Nano Pills for Co-Delivery of Epilepsy Drugs and Hydrogen in Lab Tests
Innovative oral formulations with silicon nanoparticles for co-delivery of poorly soluble drugs and hydrogen gas
Research hubs: Brain & Nervous System
This research was done on cells or tissue in a lab, not in people or animals.
- Evidence type
- Laboratory study (cells or tissue)
- Authors
- Hennie Marie Johnsen, Maria Tuyet Nhi Nguyen, Tove Larsen, Werner Filtvedt, Marianne Hiorth, Jo Klaveness
- Journal
- International Journal of Pharmaceutics
- Year
- 2026
- PMID
- 41936893
- Study Type
- Molecular Assay
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- Norway
TL;DR
Porous silicon nanoparticles were able to co-deliver anti-epileptic drugs and generate hydrogen under mildly alkaline conditions, but drug loading and formulation choices reduced hydrogen output and showed the need for further optimization.
Key Finding
Silicon nanoparticles can successfully deliver both anti-epilepsy drugs and hydrogen gas through a single oral formulation, though the drug and hydrogen components compete with each other—adding drug reduced hydrogen release.
Summary
Researchers developed a new type of nanoparticle (tiny particle) made from silicon that could deliver two things at once: anti-epilepsy drugs and hydrogen gas. The silicon nanoparticles were designed to release hydrogen gas when they came into contact with the slightly alkaline environment of the intestines. The team tested whether these particles could be made into tablets or capsules and found that while the approach works, the presence of the drug reduced how much hydrogen gas was released, and capsules worked better than tablets for hydrogen generation.
Practical Takeaway
This is early laboratory research with no human testing, so it's far too preliminary to indicate what benefits hydrogen water or hydrogen-releasing formulations might have for people. The study shows the technology is theoretically feasible, but significant work remains to optimize the formulation before any clinical applications could be considered.
Abstract (excerpt)
Nanomedicine offers new opportunities for combination therapy by co-delivering multiple active pharmaceutical ingredients (APIs) for improved convenience and synergistic effects. Recently, hydrogen gas (H2) has gained attention for its antioxidant effects suitable for treating a wide variety…